Case Study: a multi-national european pharmaceutical and consumer health company validates nasal spray product safety and performance with ObvioHealth

Post-Market Clinical Follow-Up Studies in 5 European Countries

A multi-national European pharmaceutical and consumer health company required clinical data to validate the safety and performance of five of its nasal spray and allergy products to meet post-market regulatory requirements. The challenge involved conducting these studies across multiple European countries and capturing data on user experience and any adverse events.

ObvioHealth, in partnership with IQVIA Consumer Health, designed and executed all five digital studies. Their solution included multi-language materials, digital recruitment targeting recent product users, and simple electronic questionnaires completed via the ObvioGo mobile app to ensure high compliance. As a result, ObvioHealth completed recruitment under budget and finished the studies early, with an average duration of 48 days, providing the client with valuable insights into product use and satisfaction.